Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-10

Clinical Trial Update: Tolerance & Responsiveness Improvement for Metformin (TRIM) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on tolerance and responsiveness improvement for metformin in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: West Side Institute for Science and Education | Conditions: Type2 Diabetes Mellitus | Phase 4 | Status: COMPLETED